Hookipa would raise $101M if IPO prices at midpoint

Infectious disease and cancer vaccine company Hookipa proposed to sell 6.7 million shares at $14-$16 in its IPO, according to a prospectus for the offering.

If priced at the midpoint of the proposed range, Hookipa Pharma Inc. (New York, N.Y.) would raise $100.5 million and be valued at $391.1 million...